Policies and institutional arrangements for rationalizing drug selection and consumption patterns in African healthcare systems

Research in Social and Administrative Pharmacy

Volumn 5, Issue 3, 2009, Pages 274-285

  Tetteh, Ebenezer Kwabena ^a  

^a Office of Health Economics   (United Kingdom)

Author keywords

Affordability; Africa; Drug selection consumption; Medicines management; Model mix

Indexed keywords

EID: 69449104304     PISSN: 15517411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sapharm.2008.08.007     Document Type: Note

References (35)

1. WHO. Promoting Rational Use of Medicines: Core Components. WHO/EDM/2002.3. 2002a.
2. WHO. The World Medicines Situation. WHO/EDM/PAR/2004.5. 2004a.
3. Elbasha E.H. Deadweight loss of bacterial resistance due to over-treatment. Health Econ 12 (2003) 125-138
4. WHO. 2006. Progress in the rational use of medicines, including better medicines for children. Report by the Secretariat: 120th Session of the Executive Board. Available at: ftp.who.int/gb/ebwha/pdf_files/EB120/b120_7-en.pdf Accessed September 29, 2007.
5. Laing R.O., Hogerzeil H.V., and Ross-Degnan D. Ten recommendations to improve drug use in developing countries. Health Policy Plan 16 1 (2001) 13-20
6. WHO. The Selection of Essential Medicines. WHO/EDM/2002.2. 2002b.
7. US FDA. Approved drug products with therapeutic equivalence evaluations. Available at: (2007). http://www.fda.gov/cder/ob/docs/preface/eclink.htm Accessed April 27, 2007
8. Schweitzer S.O. Pharmaceutical Economics and Policy (1997), Oxford University Press, New York
9. WHO. How to develop a national formulary based on the WHO model formulary: a practical guide. WHO/EDM/PAR/2004.8 (2004)
10. Tetteh E.K. Providing affordable essential medicines to African households: the missing policies and institutions for price containment. Soc Sci Med 66 3 (2008) 569-581
11. World Bank. Importance of pharmaceuticals and essential drug programs in Better Health for Africa: experience and lessons learned. Available at (1994). www.worldbank.org AccessedJune 5, 2006
12. Mossialos E. Regulating expenditures on medicines in European health care systems. In: Saltman R.B., Figueras J., and Sakellarides C. (Eds). Critical challenges for health sector reform in Europe (1999), Open University Press, Maidenhead 261-283
13. WHO. A short manual on Tanzania National Drug policy: the masterplan for the pharmaceutical sector 1992-2000. Available at (1993). http://82.77.46.162:8080/gsd/cgi-bin/whocountry/library.fcgi Accessed October 5, 2007
14. Yudkin J.S. The economics of pharmaceutical supply in Tanzania. Int J Health Serv 10 3 (1980) 455-477
15. Kuhn M. Quality in Primary Care: Economic Approaches to Analyzing Quality-Related Physician Behaviour (2003), Office of Health Economics, London
16. Chaix-Couturier C., Durand-Zaleski I., Jolly D., and Durieux P. Effects of financial incentives on medical practice: results from a systematic review of literature and methodological issues. Int J Qual Health care 12 2 (2000) 133-142
17. Robinson J.C. Theory and practice in the design of physician payment incentives. Milbank Q 79 2 (2001) 149-177
18. Propper C., and Wilson D. The use of performance measures in healthcare systems. In: Jones A. (Ed). The Elgar companion to health economics (2006), Edward Elgar, Cheltenham 326-334
19. Soeters R., Musango L., and Meessen B. Comparisons of two output-based schemes in Butare and Cyangugu provinces with two control provinces in Rwanda. Global Partnership on Output-Based Aid (GPOBA) (2005), World Bank, Ministry of Health, Rwanda
20. Meessen B., Kashala J.-P., and Musango L. Output-based payment to boost staff productivity in public health centers: Contracting in Kabutare district, Rwanda. Bulletin of the World Health Organisation 85 (2007) 108-115
21. Partridge M.R. Translating research into practice: how are guidelines implemented?. Eur Respir J 21 Suppl. 39 (2003) 23-29
22. Levine S., Campen D., Millares M., and Barrueta A. Kaiser Permanente's prescription drug benefit. Health Affairs 19 2 (2000) 185-190
23. Pagnoni F., Convelbo N., Tiendrebeogo J., Cousens S., and Esposito F. A community-based programme to provide prompt and adequate treatment of presumptive malaria in children. Trans Royal Soc Trop Med Hyg 91 5 (1997) 512-517
24. Gafni A., Charles C., and Whelan T. The physician-patient encounter: the physician as a perfect agent for the patient versus the informed treatment decision-making model. Soc Sci Med 47 3 (1998) 347-354
25. Horne R. Patients' beliefs about treatment: The hidden determinant of treatment outcome?. J Psychosom Res 47 6 (1999) 491-495
26. Lamiraud K., and Geoffard P.-V. Therapeutic non-adherence: A rational behaviour revealing patient preferences?. Health Econ 16 (2007) 1185-1204
27. Etkin N., Ross J., and Muazzamu T. The indigenization of pharmaceuticals: therapeutic transitions in rural Hausaland. Soc Sci Med 30 8 (1990) 919-928
28. Bradley C., Hansen E.H., and Kooiker S. Patients and Their Medicines. In: Mossialos E., Mrazek M., and Walley T. (Eds). Regulation of pharmaceuticals in Europe: striving for efficiency, equity and quality (2004), Open University Press, Maidenhead 158-176
29. Loevinsohn B.P. Health education interventions in developing countries: a methodological review of published articles. Int J Epidemiol 19 4 (1990) 788-794
30. Wright J.M., Htun Y., Leong M.G., Forman P., and Ballard R.C. Evaluation of the use of calendar blister packaging on patient compliance with STD syndromic treatment regimens. Sex Transm Dis 26 10 (1999) 556-563
31. Kidane G., and Morrow R.H. Teaching mothers to provide home treatment of malaria in Tigray, Ethiopia: a randomized trial. Lancet 356 9229 (2000) 550-555
32. Pauly M.V. Nonprofit firms in medical markets. Am Econ Rev 77 2 (1987) 257-262
33. Le Grand J. Motivation, agency and public policy: of knights & knaves, pawns & queens (2003), Oxford University Press, New York
34. Maiga F.I., Haddad S., Fournier S.P., and Gauvin L. Public and private sector responses to essential drugs: a multilevel analysis of drug prescription and selling practices in Mali. Soc Sci Med 57 5 (2003) 937-948
35. Conway S., and White S. Co-creating health systems. Presentation at Re-Action, 16 May 2006. Available at (2006). http://www.who.int/management/meetings/en/index6.html Accessed August 1 2008